Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Huey

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Active molecular iodine photochemistry in the ArcticAngela R W Raso, Kyle D Custard, Nathaniel W May, et al.
European Journal of Medicinal Chemistry|May 26, 2021
UNC5293, a potent, orally available and highly MERTK-selective inhibitorHongchao Zheng, Jichen Zhao, Bing Li, et al.
JCI Insight|December 3, 2020
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
Science (New York, N.Y.)|April 28, 2001
Observations of ozone formation in power plant plumes and implications for ozone control strategiesT B Ryerson, M Trainer, J S Holloway, et al.
JCI Insight|May 10, 2016
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemiaKatherine A Minson, Catherine C Smith, Deborah DeRyckere, et al.
Journal of the American Chemical Society|September 10, 2019
Data-Driven Construction of Antitumor Agents with Controlled PolypharmacologyChenxiao Da, Dehui Zhang, Michael Stashko, et al.
Neuroscience|September 22, 2014
Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeP M Grace, K M Ramos, K M Rodgers, et al.
Bulletin of the American Meteorological Society|April 12, 2018
The Convective Transport of Active Species in the Tropics (CONTRAST) ExperimentL L Pan, E L Atlas, R J Salawitch, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Active molecular iodine photochemistry in the ArcticAngela R W Raso, Kyle D Custard, Nathaniel W May, et al.
European Journal of Medicinal Chemistry|May 26, 2021
UNC5293, a potent, orally available and highly MERTK-selective inhibitorHongchao Zheng, Jichen Zhao, Bing Li, et al.
JCI Insight|December 3, 2020
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
Science (New York, N.Y.)|April 28, 2001
Observations of ozone formation in power plant plumes and implications for ozone control strategiesT B Ryerson, M Trainer, J S Holloway, et al.
JCI Insight|May 10, 2016
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemiaKatherine A Minson, Catherine C Smith, Deborah DeRyckere, et al.
Journal of the American Chemical Society|September 10, 2019
Data-Driven Construction of Antitumor Agents with Controlled PolypharmacologyChenxiao Da, Dehui Zhang, Michael Stashko, et al.
Neuroscience|September 22, 2014
Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeP M Grace, K M Ramos, K M Rodgers, et al.
Bulletin of the American Meteorological Society|April 12, 2018
The Convective Transport of Active Species in the Tropics (CONTRAST) ExperimentL L Pan, E L Atlas, R J Salawitch, et al.
Pageof 2